Advertisement ProCure and University of Pennsylvania collaborate to develop radiation therapy - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

ProCure and University of Pennsylvania collaborate to develop radiation therapy

ProCure Treatment Centers and the University of Pennsylvania's Roberts Proton Therapy Center have signed an agreement to provide advanced training programs and accredit medical professionals in proton therapy, an alternative to conventional radiation therapy that avoids many of the side effects inherent in treatment.

The agreement mainly focuses on expanding research on the technology to be used for the delivery of proton therapy and developing new protocols using protons to treat a wider range of cancer tumors.

Niek Schreuder, senior vice president of technology at ProCure, said: “By partnering with a world renowned academic institution that has a strong interest in furthering the use of proton therapy, we can significantly enhance the caliber of training programs at the Training and Development Center.”